Dermatology Clinical Trials in New York, NY

As of June 2026, 51 paid clinical trials are recruiting for Dermatology in New York, New York. Dermatology trials test biologics, JAK inhibitors, and novel topical therapies for psoriasis, atopic dermatitis, hidradenitis suppurativa, melanoma, and other inflammatory and oncologic skin conditions. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

51 clinical trials for Dermatology

·Clear filters·↓ Download CSV

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

for Melanoma

31 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 16+

Code: NCT05355701·Phase 1·Recruiting

Apply to this trial

Multi-Center PAMPA Study

for Psoriasis

3 locations incl. Boston

Sponsor: NYU Langone Health

Sex: All·Age: 18+

Code: NCT05004727·Phase 4·Recruiting

Apply to this trial

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for Colorectal Carcinoma

21 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 12 Months - 30

Code: NCT04851119·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

for Head and Neck Cancer

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05053230·Recruiting

Apply to this trial

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for Cervical Cancer

11 locations incl. Clovis

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT04895709·Phase 1, Phase 2·Recruiting

Apply to this trial

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

for Advanced Malignancies

3 locations incl. Duarte

Sponsor: BioInvent International AB

Sex: All·Age: 18+

Code: NCT04752826·Phase 1, Phase 2·Recruiting

Apply to this trial

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

for Melanoma

Drug: Cemiplimab

23 locations incl. Phoenix

Sponsor: Vyriad, Inc.

Sex: All·Age: 18+

Code: NCT04291105·Phase 2·Recruiting

Apply to this trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for Autoimmune Disease

Drug: Nivolumab

51 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03816345·Phase 1·Recruiting

Apply to this trial

Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

for Skin Cancer

5 locations incl. Sacramento

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 21+

Code: NCT03503240·Enrolling By Invitation

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for Cancer, Metastatic

67 locations incl. Birmingham

Sponsor: Massive Bio, Inc.

Sex: All·Age: All ages

Code: NCT03452774·Recruiting

Apply to this trial

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for Melanoma

7 locations incl. Aurora

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 6 Months - 17

Code: NCT02332668·Phase 1, Phase 2·Recruiting

Apply to this trial

Conditions in Dermatology (New York, NY)

Melanoma· 23 Atopic dermatitis / eczema· 12 Hidradenitis suppurativa· 8 Skin cancer· 5 Psoriasis· 3